Lithium Pharmacodynamics and Pharmacogenetics: Focus on Inositol Mono Phosphatase (IMPase), Inositol Poliphosphatase (IPPase) and Glycogen Sinthase Kinase 3 Beta (GSK-3 Beta)

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|15|1917-1948

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.15, 2009-05, pp. : 1917-1948

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1421-1434

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2790-2798

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes

By MacAulay Katrina   Woodgett James R  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1265-1274

Informa Healthcare

Access to resources Recommend Favorite

The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 22, 2011-07 ,pp. : 2264-2277

Bentham Science Publishers

Access to resources Recommend Favorite